BR9709858A - Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto - Google Patents
Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um compostoInfo
- Publication number
- BR9709858A BR9709858A BR9709858A BR9709858A BR9709858A BR 9709858 A BR9709858 A BR 9709858A BR 9709858 A BR9709858 A BR 9709858A BR 9709858 A BR9709858 A BR 9709858A BR 9709858 A BR9709858 A BR 9709858A
- Authority
- BR
- Brazil
- Prior art keywords
- compound
- diseases
- endocrinological system
- treatment
- manufacture
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/541—Non-condensed thiazines containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/15—Six-membered rings
- C07D285/16—Thiadiazines; Hydrogenated thiadiazines
- C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines
- C07D285/20—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems
- C07D285/22—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D285/24—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with oxygen atoms directly attached to the ring sulfur atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/02—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing not further condensed quinuclidine ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D453/00—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids
- C07D453/06—Heterocyclic compounds containing quinuclidine or iso-quinuclidine ring systems, e.g. quinine alkaloids containing isoquinuclidine ring systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pyridine Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DK69396 | 1996-06-21 | ||
DK145196 | 1996-12-19 | ||
PCT/DK1997/000266 WO1997049692A1 (en) | 1996-06-21 | 1997-06-19 | 1,2,4-benzothiadiazine derivatives, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
BR9709858A true BR9709858A (pt) | 1999-08-10 |
Family
ID=26064470
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR9709858A BR9709858A (pt) | 1996-06-21 | 1997-06-19 | Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto |
Country Status (18)
Country | Link |
---|---|
US (1) | US6242443B1 (pt) |
EP (1) | EP0906297B1 (pt) |
JP (1) | JP2000512641A (pt) |
KR (1) | KR20000022087A (pt) |
CN (1) | CN1081633C (pt) |
AT (1) | ATE260266T1 (pt) |
AU (1) | AU737920B2 (pt) |
BR (1) | BR9709858A (pt) |
CA (1) | CA2258100A1 (pt) |
CZ (1) | CZ413198A3 (pt) |
DE (1) | DE69727806T2 (pt) |
ES (1) | ES2216155T3 (pt) |
HU (1) | HUP9904032A3 (pt) |
IL (1) | IL127368A0 (pt) |
MX (1) | MXPA98010773A (pt) |
NO (1) | NO985979L (pt) |
PL (1) | PL330815A1 (pt) |
WO (1) | WO1997049692A1 (pt) |
Families Citing this family (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1998049146A2 (en) * | 1997-04-28 | 1998-11-05 | The United States Of America, Represented By The Secretary Department Of Health & Human Services, The National Institutes Of Health | Cyclin dependent kinase (cdk)4 inhibitors and their use for treating cancer |
AU1555999A (en) * | 1997-12-19 | 1999-07-12 | Novo Nordisk A/S | 1,2,4-benzothiadiazine derivatives, their preparation and use |
US6943159B1 (en) | 1998-02-18 | 2005-09-13 | Neurosearch A/S | Compounds and their use as positive AMPA receptor modulators |
AU2001265840A1 (en) * | 2000-06-26 | 2002-01-08 | Novo-Nordisk A/S | Use of potassium channel agonists for reducing fat food comsumption |
EP1368327B1 (en) * | 2001-02-14 | 2004-10-20 | Warner-Lambert Company LLC | Benzo thiadiazine matrix metalloproteinase inhibitors |
AU2004270162B2 (en) | 2003-08-28 | 2010-05-13 | Nicox S.A. | Nitrosated ad nitrosylated diuretic compouds, compositions and methods of use |
WO2006091716A2 (en) | 2005-02-24 | 2006-08-31 | Nitromed, Inc. | Nitric oxide enhancing diuretic compounds, compositions and methods of use |
BRPI0713684A2 (pt) * | 2006-06-22 | 2012-10-30 | Anadys Pharmaceuticals Inc | compostos, composição farmaceuticamente aceitável e métodos de inibição da replicação de vìrus da hepatite c, de tratamento de célula e de tratamento ou prevenção da infecção do vìrus da hepatite c em maìfero carecido do mesmo |
CN102026990A (zh) * | 2008-04-15 | 2011-04-20 | 因特蒙公司 | 丙型肝炎病毒复制的新颖抑制剂 |
US20120053172A1 (en) | 2009-02-12 | 2012-03-01 | Cooperatieve Mirzorg U.A. | Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders |
WO2010111518A1 (en) * | 2009-03-27 | 2010-09-30 | Yale University | Treatment and prevention of white matter injury with katp channel activators |
TW201121968A (en) * | 2009-11-09 | 2011-07-01 | Intermune Inc | Novel inhibitors of hepatitis C virus replication |
EP3099304A4 (en) | 2014-01-31 | 2018-01-10 | Mayo Foundation for Medical Education and Research | Novel therapeutics for the treatment of glaucoma |
WO2017098421A1 (en) * | 2015-12-08 | 2017-06-15 | Glaxosmithkline Intellectual Property Development Limited | Benzothiadiazine compounds |
WO2019217834A1 (en) * | 2018-05-11 | 2019-11-14 | University Of Florida Research Foundation, Incorporated | Myelination stimulator compounds, and methods of treatment |
NL2022291B1 (en) * | 2018-12-21 | 2020-07-21 | Academisch Ziekenhuis Leiden | Compound for Use in Treatment and Prevention of Type I Diabetes |
CN110903264B (zh) * | 2019-12-26 | 2021-06-18 | 苏州大学 | 一种制备二氮嗪的方法 |
US20230219912A1 (en) * | 2020-05-19 | 2023-07-13 | Board Of Regents Of The University Of Nebraska | Halogenated benzothiadiazines for the treatment of cancer |
WO2024086252A1 (en) * | 2022-10-18 | 2024-04-25 | Rhythm Pharmaceuticals, Inc. | Novel atp-sensitive potassium channel potentiators, their preparation and use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3269906A (en) | 1966-08-30 | Imino-j,x-dihydro-l,z,x-benzothiadiazine- i,i-dioxides | ||
GB847176A (en) * | 1958-06-20 | 1960-09-07 | Lepetit Spa | Benzothiadiazine compounds |
US4029780A (en) * | 1974-10-29 | 1977-06-14 | Dainippon Pharmaceutical Co., Ltd. | 3-Piperazinyl 1,2,4-benzothiadiazine 1,1-dioxide derivatives their compositions and method of use |
SE402773B (sv) | 1976-04-20 | 1978-07-17 | Dainippon Pharmaceutical Co | Forfarande for framstellning av 1,2,4-bensotiadiazin-1,1-dioxid-derivat |
DE2757922A1 (de) * | 1977-12-24 | 1979-06-28 | Bayer Ag | Substituierte alkylenamino-1.2.4- benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
DE2757925A1 (de) * | 1977-12-24 | 1979-06-28 | Bayer Ag | Diazacyclo-1.2.4-benzothiadizine, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
-
1997
- 1997-06-17 US US08/877,456 patent/US6242443B1/en not_active Expired - Fee Related
- 1997-06-19 EP EP97927017A patent/EP0906297B1/en not_active Expired - Lifetime
- 1997-06-19 KR KR1019980710491A patent/KR20000022087A/ko not_active Application Discontinuation
- 1997-06-19 PL PL97330815A patent/PL330815A1/xx unknown
- 1997-06-19 ES ES97927017T patent/ES2216155T3/es not_active Expired - Lifetime
- 1997-06-19 AU AU31664/97A patent/AU737920B2/en not_active Ceased
- 1997-06-19 WO PCT/DK1997/000266 patent/WO1997049692A1/en not_active Application Discontinuation
- 1997-06-19 JP JP10502127A patent/JP2000512641A/ja not_active Withdrawn
- 1997-06-19 IL IL12736897A patent/IL127368A0/xx unknown
- 1997-06-19 CZ CZ984131A patent/CZ413198A3/cs unknown
- 1997-06-19 AT AT97927017T patent/ATE260266T1/de not_active IP Right Cessation
- 1997-06-19 CN CN97195677A patent/CN1081633C/zh not_active Expired - Fee Related
- 1997-06-19 HU HU9904032A patent/HUP9904032A3/hu unknown
- 1997-06-19 CA CA002258100A patent/CA2258100A1/en not_active Abandoned
- 1997-06-19 BR BR9709858A patent/BR9709858A/pt unknown
- 1997-06-19 DE DE1997627806 patent/DE69727806T2/de not_active Expired - Lifetime
- 1997-06-19 MX MXPA98010773A patent/MXPA98010773A/es unknown
-
1998
- 1998-12-18 NO NO985979A patent/NO985979L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE69727806D1 (de) | 2004-04-01 |
IL127368A0 (en) | 1999-10-28 |
CN1081633C (zh) | 2002-03-27 |
WO1997049692A1 (en) | 1997-12-31 |
EP0906297A1 (en) | 1999-04-07 |
DE69727806T2 (de) | 2005-01-13 |
MXPA98010773A (es) | 2002-06-11 |
HUP9904032A2 (hu) | 2000-03-28 |
CN1222910A (zh) | 1999-07-14 |
CA2258100A1 (en) | 1997-12-31 |
KR20000022087A (ko) | 2000-04-25 |
AU3166497A (en) | 1998-01-14 |
ATE260266T1 (de) | 2004-03-15 |
ES2216155T3 (es) | 2004-10-16 |
JP2000512641A (ja) | 2000-09-26 |
US6242443B1 (en) | 2001-06-05 |
CZ413198A3 (cs) | 1999-06-16 |
NO985979D0 (no) | 1998-12-18 |
AU737920B2 (en) | 2001-09-06 |
NO985979L (no) | 1999-02-19 |
EP0906297B1 (en) | 2004-02-25 |
HUP9904032A3 (en) | 2001-11-28 |
PL330815A1 (en) | 1999-06-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR9709858A (pt) | Composto composição farmacêutica uso do composto e processos para tratamento de doenças do sistema endocrinólogico para fabricação de um medicamento específico para ser usado no tratamento de doenças do sistema endocrinológico e para preparação de um composto | |
BR9810592A (pt) | Composto, processos para preparar um composto, para tratar ou prevenir doenças do sistema endócrino e para a fabricação de um medicamento, composição farmacêutica, e, uso de um composto | |
BR9407910A (pt) | Composto composiçao farmacêutica uso do composto processo de tratamento de distúrbios no sistema nervoso central e processo de preparaçao do composto | |
DE69011059T2 (de) | Heterozyklische Acylaminothiazolderivate, ihre Herstellung und diese enthaltende pharmazeutische Zubereitungen. | |
RU94040864A (ru) | Конденсированные индольные производные, их получение, фармацевтическая композиция | |
ATA285187A (de) | Substituierte alpha-aminosaeuren, ihre herstellung und diese enthaltende arzneimittel | |
ATE188965T1 (de) | Neue pyrazincarboxamidderivate, ihre herstellung und ihre verwendung in arzneimitteln | |
RU93004793A (ru) | Производные хиназолина, способ их получения, фармацевтическая композиция на их основе | |
RU93004860A (ru) | Гетероциклические соединения, способ их получения, использование и фармацевтическая композиция | |
FI940696A0 (fi) | Uudet pyratsiinijohdannaiset, niiden valmistus ja käyttö | |
DE3751036D1 (de) | Durch Carnitin dirigierte pharmazeutische Substanzen und ihre Verwendung zur Herstellung eines Arzneimittels zur Behandlung von Muskelerkrankungen. | |
BR9809234A (pt) | Composto, composição farmacêutica, uso de um composto, processos para tratar ou prevenir doenças do sistema endocrinológico, para fabricar um medicamento, para preparar um composto e um conjunto, conjunto, e, uso do mesmo. | |
ATE247645T1 (de) | Neue piperazinylalkylthiopyrimidine derivate, diese enthaltende pharmazeutische zusammenstellungen und verfahren zu deren herstellung | |
AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
ATE100095T1 (de) | 2,2-dimethylchromenderivate, verfahren zur herstellung und diese enthaltende pharmazeutische zusammenstellungen. | |
ATE218535T1 (de) | Aminotetralinderivate, deren zusammensetzungen sowie deren verwendung | |
ATE55248T1 (de) | Arzneimittelkombination. | |
PT1025101E (pt) | Derivados de nafto-imidazo¬1,2-a|piridina sua preparacao e uso no tratamento de perturbacoes do sistema nervoso central | |
EE03803B1 (et) | a-amino- ja tsüklopentaan-ß-aminohapet(-happeid) ja/või nende derivaate sisaldavad segud ja dipeptiidid, dipeptiidide valmistamismeetod ning nimetatud segusid ja/või dipeptiide sisaldavad ravimid | |
BR9707004A (pt) | Composto processo para preparar o mesmo composição farmacêutica utilização do composto e processos para tratamento de doenças do sistema endocinológico e para a manufatura de um medicamento | |
DE69512419T2 (de) | IMIDAZO[1,2-a]INDENO[1,2-e]PYRAZIN-2-CARBONSÄURE DERIVATE, IHRE HERSTELLUNG UND SIE ENTHALTENDE ARZNEIMITTEL | |
DK0538690T3 (da) | Arylquinolyl-substituerede 1,4-dihydropyridin-dicarboxylsyrederivater, fremgangsmåde til deres fremstilling af deres anvendelse i lægemidler | |
FI865220A0 (fi) | Foerfarande foer framstaellning av sulfinyl- och sulfonylsubstituerade 3-benzazepiner. | |
DE69102143T2 (de) | Spiramycin enthaltende arzneimittel und verfahren zu deren herstellung. | |
ATE69809T1 (de) | Leukotrienantagonisten, verfahren zu ihrer herstellung, ihre anwendung zur behandlung von krankheiten. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |